Moffitt | Strategic Alliance Partners

Latest from Moffitt

Dr. Wenham on Rationale for Novel Immunotherapy Combos in Ovarian Cancer

February 24, 2021

Video

Robert Wenham, MD, MS, FACOG, FACS, discusses novel immunotherapy combinations for the treatment of patients with ovarian cancer.

Dr. Chern on Opportunities for PARP Combinations in Recurrent Ovarian Cancer

February 16, 2021

Video

Jing-Yi Chern, MD, ScM, discusses efforts being made to combine PARP inhibitors with chemotherapy and immunotherapy in patients with recurrent ovarian cancer.

Ovarian Cancer: Chaired by Robert Wenham, MD, MS, FACOG, FACS

February 03, 2021

Video

Early detection, personalized treatment approaches, and increased situational awareness have improved cancer patient survival rates. Ongoing dialogue among leading experts can only improve patient outcomes and advance the field of ovarian cancer.

Dr. Hwu on the Uptake of Cellular Therapy in Oncology

February 02, 2021

Video

Patrick Hwu, MD, discusses the uptake of cellular therapy in the treatment of patients with cancer.

Emerging Therapies May Offer Fresh Options for TP53-Mutated MDS

January 13, 2021

Article

Two novel treatments options may shake up the landscape for treating patients with myelodysplasia syndrome.

Dr. Sweet on Key Findings From the OPTIC Trial With Ponatinib in CML

January 07, 2021

Video

Kendra Sweet, MD, discusses key findings from the OPTIC trial with ponatinib in chronic myeloid leukemia.